Paradigm Capital Management Inc Amarin Corp Plcuk Transaction History

Paradigm Capital Management Inc

  • $2.07 Billion
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 03, 2020
SELL
$4.78 - $8.26 $768,624 - $1.33 Million
-160,800 Closed
0 $0
Q1 2020

May 12, 2020
SELL
$4.0 - $21.53 $99,200 - $533,944
-24,800 Reduced 13.36%
160,800 $643,000
Q3 2019

Nov 07, 2019
BUY
$13.89 - $23.16 $2.58 Million - $4.3 Million
185,600 New
185,600 $2.81 Million

Others Institutions Holding AMRN

# of Institutions
184
Shares Held
87.9M
Call Options Held
528K
Put Options Held
219K
View Full List

About AMARIN CORP PLCUK

AMRN Quotes by TradingView
  • Ticker AMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 403,206,016
  • Market Cap $278M
  • Description
  • Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...
More about AMRN
Track This Portfolio

Track Paradigm Capital Management Inc Portfolio

Follow Paradigm Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Paradigm Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Paradigm Capital Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email